Search research articles
Contact Us
Filters
Showing results (1-10 of 218) with videos related to
Page
of 22
Sort By:
ESC Heart Failure
|
October 7, 2016
Facts and numbers on epidemiology and pharmacological treatment of heart failure with preserved ejection fraction
Frank Edelmann
European Journal of Heart Failure
|
June 19, 2022
Closing the gap, or the beauty of alleviating our patients' symptoms
Johannes Petutschnigg, Frank Edelmann
Der Internist
|
August 22, 2019
[Heart failure with preserved left ventricular ejection fraction]
Johannes Petutschnigg, Frank Edelmann
Heart Failure Clinics
|
July 1, 2014
Diagnosis of heart failure with preserved ejection fraction
Rolf Wachter, Frank Edelmann
Deutsche Medizinische Wochenschrift (1946)
|
January 29, 2024
[Diagnosis of heart failure with preserved ejection fraction]
Daniela Zurkan, Frank Edelmann
Frontiers in Cardiovascular Medicine
|
June 7, 2023
Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy
Andrea Deichl, Frank Edelmann
Cardiovascular Diabetology
|
June 29, 2023
The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
Ulrich Kintscher, Frank Edelmann
Circulation. Heart Failure
|
April 18, 2023
Letter by Kambic et al Regarding Article, "A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction"
Tim Kambic, Frank Edelmann, Mitja Lainscak
Herz
|
June 8, 2022
Comorbidities in heart failure with preserved ejection fraction
Andrea Deichl, Rolf Wachter, Frank Edelmann
European Heart Journal
|
February 6, 2024
Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?
Daniela Zurkan, Bertram Pitt, Frank Edelmann
Page
of 22
Search research articles
Search
Showing results (1-10 of 218) with videos related to
Sort By:
Page
of 22
ESC Heart Failure
|
October 7, 2016
Facts and numbers on epidemiology and pharmacological treatment of heart failure with preserved ejection fraction
Frank Edelmann
European Journal of Heart Failure
|
June 19, 2022
Closing the gap, or the beauty of alleviating our patients' symptoms
Johannes Petutschnigg, Frank Edelmann
Der Internist
|
August 22, 2019
[Heart failure with preserved left ventricular ejection fraction]
Johannes Petutschnigg, Frank Edelmann
Heart Failure Clinics
|
July 1, 2014
Diagnosis of heart failure with preserved ejection fraction
Rolf Wachter, Frank Edelmann
Deutsche Medizinische Wochenschrift (1946)
|
January 29, 2024
[Diagnosis of heart failure with preserved ejection fraction]
Daniela Zurkan, Frank Edelmann
Frontiers in Cardiovascular Medicine
|
June 7, 2023
Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy
Andrea Deichl, Frank Edelmann
Cardiovascular Diabetology
|
June 29, 2023
The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
Ulrich Kintscher, Frank Edelmann
Circulation. Heart Failure
|
April 18, 2023
Letter by Kambic et al Regarding Article, "A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction"
Tim Kambic, Frank Edelmann, Mitja Lainscak
Herz
|
June 8, 2022
Comorbidities in heart failure with preserved ejection fraction
Andrea Deichl, Rolf Wachter, Frank Edelmann
European Heart Journal
|
February 6, 2024
Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?
Daniela Zurkan, Bertram Pitt, Frank Edelmann
Page
of 22